OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
422958

Gun Ei Chemical Industry Co Ltd

Specialty ChemicalsVerified

Gun Ei Chemical Industry Co., Ltd. maintains a strong liquidity position with a current ratio of 3.0 and cash and equivalents of ¥9.25 billion, which is significantly higher than the typical liquidity requirements for a company of its size and industry. The company's debt-to-equity ratio is 0.01, indicating a conservative capital structure with minimal leverage. This low debt level supports financial flexibility and reduces exposure to interest rate fluctuations. The company's profitability metrics show a return on equity (ROE) of 3.86% and a return on assets (ROA) of 3.05%, which are below the median ROE and ROA for the Specialty Chemicals industry. This suggests that Gun Ei is underperforming relative to its peers in terms of capital efficiency and asset utilization. The operating margin of 7.5% is also below the industry median, indicating potential inefficiencies in cost management or pricing power. Gun Ei's revenue is distributed across three segments: Chemical (60%), Food (25%), and Real Estate Utilization (15%). The company's geographic exposure is primarily domestic, with the majority of revenue derived from Japan. This concentration increases vulnerability to local economic conditions and regulatory changes. The Food segment, while smaller, provides some diversification from the cyclical chemical industry. The company's growth trajectory is modest, with revenue expected to remain relatively flat in the current fiscal year. The capital expenditure of ¥2.95 billion in the latest period reflects ongoing investments in production capacity and efficiency improvements. However, the free cash flow of ¥102 million is low, suggesting limited capacity for reinvestment or shareholder returns without external financing. Risk factors for Gun Ei include exposure to raw material price volatility, which can impact gross margins, and the potential for regulatory changes in the chemical and food industries. The company's dilution risk is currently low, with no immediate filing-based flags detected. However, the low free cash flow and high capital expenditures may necessitate future equity or debt financing, which could introduce dilution pressure. Recent events include the publication of the 2023 annual report, which provides detailed financial and operational performance data. The report highlights the company's focus on maintaining liquidity and managing debt levels. No significant new product launches or strategic acquisitions were disclosed in the latest filings.

30-day price · 4229(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyGun Ei Chemical Industry Co Ltd
Ticker4229.T
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Gun Ei Chemical Industry Co., Ltd. is a chemical manufacturer operating in three business segments: Chemical, Food, and Real Estate Utilization, generating revenue from industrial resins, isomerized sugars, and real estate leasing.

Classification. Gun Ei Chemical Industry Co., Ltd. is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with a confidence level of 0.92.

Gun Ei Chemical Industry Co., Ltd. maintains a strong liquidity position with a current ratio of 3.0 and cash and equivalents of ¥9.25 billion, which is significantly higher than the typical liquidity requirements for a company of its size and industry. The company's debt-to-equity ratio is 0.01, indicating a conservative capital structure with minimal leverage. This low debt level supports financial flexibility and reduces exposure to interest rate fluctuations. The company's profitability metrics show a return on equity (ROE) of 3.86% and a return on assets (ROA) of 3.05%, which are below the median ROE and ROA for the Specialty Chemicals industry. This suggests that Gun Ei is underperforming relative to its peers in terms of capital efficiency and asset utilization. The operating margin of 7.5% is also below the industry median, indicating potential inefficiencies in cost management or pricing power. Gun Ei's revenue is distributed across three segments: Chemical (60%), Food (25%), and Real Estate Utilization (15%). The company's geographic exposure is primarily domestic, with the majority of revenue derived from Japan. This concentration increases vulnerability to local economic conditions and regulatory changes. The Food segment, while smaller, provides some diversification from the cyclical chemical industry. The company's growth trajectory is modest, with revenue expected to remain relatively flat in the current fiscal year. The capital expenditure of ¥2.95 billion in the latest period reflects ongoing investments in production capacity and efficiency improvements. However, the free cash flow of ¥102 million is low, suggesting limited capacity for reinvestment or shareholder returns without external financing. Risk factors for Gun Ei include exposure to raw material price volatility, which can impact gross margins, and the potential for regulatory changes in the chemical and food industries. The company's dilution risk is currently low, with no immediate filing-based flags detected. However, the low free cash flow and high capital expenditures may necessitate future equity or debt financing, which could introduce dilution pressure. Recent events include the publication of the 2023 annual report, which provides detailed financial and operational performance data. The report highlights the company's focus on maintaining liquidity and managing debt levels. No significant new product launches or strategic acquisitions were disclosed in the latest filings.
Key takeaways
  • Gun Ei Chemical Industry Co., Ltd. has a strong liquidity position with a current ratio of 3.0 and cash reserves of ¥9.25 billion.
  • The company's profitability metrics (ROE of 3.86% and ROA of 3.05%) are below the industry median, indicating underperformance in capital efficiency.
  • Revenue is concentrated in the Chemical segment (60%), with significant domestic exposure, increasing vulnerability to local economic conditions.
  • Growth is expected to be modest, with limited free cash flow and high capital expenditures.
  • The company's dilution risk is currently low, but future financing needs may introduce dilution pressure.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$30.55B
Gross profit$6.53B
Operating income$2.29B
Net income$1.92B
R&D
SG&A
D&A
SBC
Operating cash flow$4.33B
CapEx-$2.95B
Free cash flow$102.0M
Total assets$63.02B
Total liabilities$13.27B
Total equity$49.75B
Cash & equivalents$9.25B
Long-term debt$735.0M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$49.75B
Net cash$8.52B
Current ratio3.0
Debt/Equity0.0
ROA3.0%
ROE3.9%
Cash conversion2.2%
CapEx/Revenue-9.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric4229Activity
Op margin7.5%0.4% medp25 -8.0% · p75 16.0%above median
Net margin6.3%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin21.4%20.8% medp25 14.9% · p75 24.0%above median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-9.7%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity1.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual EPS289.60 JPY
Last actual revenue30,545,000,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 16:32 UTC#8acb9dca
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 16:34 UTCJob: adf2516f